| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash | 14,939,646 | 16,958,744 | ||
| Accounts receivable-Related Party | - | 9,081 | ||
| Convertible loan receivable | - | 0 | ||
| Accounts receivable-Nonrelated Party | 12,085,845 | 11,989,698 | ||
| Inventory, net | 3,385,956 | 3,511,850 | ||
| Prepaid and other assets | 714,115 | 1,200,083 | ||
| Current assets related to discontinued operations (note 3) | 100,117 | - | ||
| Total current assets | 31,225,679 | 33,669,456 | ||
| Intangible assets, net | 21,100,783 | 40,992,568 | ||
| Goodwill | 3,601,781 | 3,601,781 | ||
| Investment in equity securities | 12,588,476 | 10,515,812 | ||
| Right of use assets operating leases | 2,154,721 | 1,088,149 | ||
| Property and equipment, gross | 1,047,675 | - | ||
| Less accumulated depreciation | 630,467 | - | ||
| Property and equipment, net | 417,208 | 8,899,879 | ||
| Total long-term assets | 39,862,969 | 65,098,189 | ||
| Total assets | 71,088,648 | 98,767,645 | ||
| Accounts payable-Nonrelated Party | 1,139,794 | 1,457,301 | ||
| Accounts payable-Related Party | 27,339 | 32,355 | ||
| Accrued bonuses and commissions | 10,876,267 | 10,199,451 | ||
| Accrued royalties and expenses | 2,655,436 | 2,964,143 | ||
| Earnout liabilities current | 228,001 | 39,659 | ||
| Operating lease liabilities current | 338,990 | 182,935 | ||
| Current liabilities related to discontinued operations (note 3) | 2,092,142 | - | ||
| Total current liabilities | 17,357,969 | 14,875,844 | ||
| Earnout liabilities long-term | - | 2,110,945 | ||
| Long-term debt | 45,089,787 | 44,216,662 | ||
| Operating lease liabilities long-term | 1,963,475 | 1,051,290 | ||
| Other long-term liabilities | 536,883 | 1,120,958 | ||
| Total long-term liabilities | 47,590,145 | 48,499,855 | ||
| Total liabilities | 64,948,114 | 63,375,699 | ||
| Common stock 0.001 par value, 20,000,000 shares authorized 8,930,800 issued and outstanding as of september 30, 2025 and 8,753,773 issued and outstanding as of december 31, 2024 | 8,931 | 8,904 | ||
| Additional paid-in capital | 79,833,871 | 78,678,081 | ||
| Accumulated deficit | -73,693,846 | -43,287,572 | ||
| Total sanara medtech shareholders equity | 6,148,956 | 35,399,413 | ||
| Equity attributable to noncontrolling interest | -8,422 | -7,467 | ||
| Total shareholders equity | 6,140,534 | 35,391,946 | ||
| Total liabilities and shareholders equity | 71,088,648 | 98,767,645 | ||
Sanara MedTech Inc. (SMTI)
Sanara MedTech Inc. (SMTI)